Harvard Apparatus Regenerative Technology, Inc. (HRGN)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Product revenue | 317 | 45 | 59 | 56 |
| Sales and marketing | - | 10 | 143 | 197 |
| Research and development | 697 | 601 | 557 | 642 |
| General and administrative | 1,151 | 1,071 | 1,148 | 1,685 |
| Cost of sales | 302 | 33 | - | - |
| Sales and marketing | - | - | - | - |
| Total operating expenses | 2,150 | 1,715 | - | - |
| Cost of sales | - | - | 70 | 13 |
| Operating expenses | - | - | 1,918 | 2,537 |
| Operating loss | -1,833 | -1,670 | -1,859 | -2,481 |
| Other income | 6 | - | - | - |
| Interest income | 7 | 13 | - | - |
| Interest expense | 3 | 2 | - | - |
| Other income (expense), net | 10 | 11 | - | - |
| Other (expense) income, net | - | - | -1 | -17 |
| Net loss | -1,823 | -1,659 | -1,860 | -2,498 |
| Foreign currency translation adjustments | -1 | - | - | - |
| Comprehensive loss | -1,824 | -1,659 | -1,860 | -2,498 |
| Net income (loss) available to common stockholders, basic | - | - | -1,860 | -2,498 |
| Diluted eps | - | - | -0.12 | -0.18 |
| Diluted average shares | - | - | 15,017,591 | 14,258,511 |
| Basic and diluted net loss per share (in dollars per share) | -0.11 | -0.1 | -0.12 | -0.18 |
| Weighted average common shares outstanding, basic and diluted (in shares) | 15,918,979 | 15,918,979 | 15,017,591 | 14,258,511 |